The interplay between adipose tissue and the cardiovascular system: is fat always bad?
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Obesity is a risk factor for cardiovascular disease (CVD). However, clinical research has revealed a paradoxically protective role for obesity in patients with chronic diseases including CVD, suggesting that the biological 'quality' of adipose tissue (AT) may be more important than overall AT mass or body weight. Importantly, AT is recognised as a dynamic organ secreting a wide range of biologically active adipokines, microRNAs, gaseous messengers, and other metabolites that affect the cardiovascular system in both endocrine and paracrine ways. Despite being able to mediate normal cardiovascular function under physiological conditions, AT undergoes a phenotypic shift characterised by acquisition of pro-oxidant and pro-inflammatory properties in cases of CVD. Crucially, recent evidence suggests that AT depots such as perivascular AT and epicardial AT are able to modify their phenotype in response to local signals of vascular and myocardial origin, respectively. Utilisation of this unique property of certain AT depots to dynamically track cardiovascular biology may reveal novel diagnostic and prognostic tools against CVD. Better understanding of the mechanisms controlling the 'quality' of AT secretome, as well as the communication links between AT and the cardiovascular system, is required for the efficient management of CVD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Adipokines in inflammation and metabolic disease
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011) · Nature Reviews Immunology · doi:10.1038/nri2921 · Cited by 4,625 · cited 1×
“interleukin 6 (IL-6); Table 1).(5) AT depots distant to the large vessels and the myocardium contribute to the circulating pool of adipocytokines, affecting cardiovascular biology via the endocrine route; on the contrary, AT depots in anatomical proximity to the cardiovascular system [e.”
Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983) · Circulation · doi:10.1161/01.cir.67.5.968 · Cited by 4,241
Adipose-derived circulating miRNAs regulate gene expression in other tissues
Thomou, T., Mori, M. A., Dreyfuss, J. M., Konishi, M., Sakaguchi, M., Wolfrum, C., Rao, T. N., Winnay, J. N., Garcia-Martin, R., Grinspoon, S. K., et al. (2017) · Nature · doi:10.1038/nature21365 · Cited by 1,539 · cited 2×
“In fact, it has recently been shown that AT in mice contributes to the circulating miR pool and is able to regulate expression of proteins such as FGF21 in remote tissues in miRdependent ways.(102) Moreover, recent work has revealed that the miR expression profile of EpAT is dysregulated in individuals with CAD, promo…”
Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide
Nisoli, E., Clementi, E., Paolucci, C., Cozzi, V., Tonello, C., Sciorati, C., Bracale, R., Valerio, A., Francolini, M., Moncada, S., et al. (2003) · Science · doi:10.1126/science.1079368 · Cited by 1,243
Diversifying microRNA sequence and function
Ameres, S. L., & Zamore, P. D. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3611 · Cited by 1,175 · cited 2×
“MiRs are small, non-coding RNA molecules that bind complementary mRNA sequences, thus inhibiting their translation.(103) By regulating gene silencing, miRs influence protein synthesis and multiple cellular functions.”
MicroRNAs in metabolism and metabolic disorders
Rottiers, V., & Näär, A. M. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3313 · Cited by 1,156
Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart Failure
Kistorp, C., Faber, J., Galatius, S., Gustafsson, F., Frystyk, J., Flyvbjerg, A., & Hildebrandt, P. (2005) · Circulation · doi:10.1161/circulationaha.104.530972 · Cited by 605
Local and systemic effects of the multifaceted epicardial adipose tissue depot
Iacobellis, G. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.58 · Cited by 605
Obesity as a cardiovascular risk factor
Sowers, J. R. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.08.012 · Cited by 584 · cited 1×
“1 Cross-talk of ATwith the vascular wall Obesity has been linked to vascular disease progression.(8) Visceral AT”
The role of nitric oxide in cardiovascular diseases
NASEEM, K. (2005) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2004.09.003 · Cited by 557
Kubota, T., Kubota, N., Kumagai, H., Yamaguchi, S., Kozono, H., Takahashi, T., Inoue, M., Itoh, S., Takamoto, I., Sasako, T., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.01.018 · Cited by 435
Fitzgibbons, T. P., & Czech, M. P. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000582 · Cited by 331 · cited 3×
“Additionally, EpAT surrounds the coronary arteries, and part of it is thus regarded as PVAT.(33)”
Leptin-induced endothelial dysfunction in obesity
Korda, M., Kubant, R., Patton, S., & Malinski, T. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00479.2008 · Cited by 213 · cited 1×
“However, leptin also increases cardiovascular oxidative stress.(75) Moderately elevated plasma leptin levels, as observed in obesity, are associated with impaired endothelial function ex vivo.”
Leptin, the obesity‐associated hormone, exhibits direct cardioprotective effects
Smith, C. C. T., Mocanu, M. M., Davidson, S. M., Wynne, A. M., Simpkin, J. C., & Yellon, D. M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706834 · Cited by 153
Handa, P., Tateya, S., Rizzo, N. O., Cheng, A. M., Morgan-Stevenson, V., Han, C.-Y., Clowes, A. W., Daum, G., O'Brien, K. D., Schwartz, M. W., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.236554 · Cited by 86
Burgeiro, A., Fuhrmann, A., Cherian, S., Espinoza, D., Jarak, I., Carvalho, R. A., Loureiro, M., Patrício, M., Antunes, M., & Carvalho, E. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00384.2015 · Cited by 76 · cited 1×
“Furthermore, EpAT of patients with heart failure (HF) is characterised by impaired glucose uptake and lipolysis and by increased content of monounsaturated FFA and palmitoleic acid.(37)”
Inflammatory profile in subcutaneous and epicardial adipose tissue in men with and without diabetes
Bambace, C., Sepe, A., Zoico, E., Telesca, M., Olioso, D., Venturi, S., Rossi, A., Corzato, F., Faccioli, S., Cominacini, L., et al. (2014) · Heart and Vessels · doi:10.1007/s00380-012-0315-9 · Cited by 73 · cited 3×
“associated with decreased expression of adiponectin and increased expression of pro-inflammatory molecules such as MCP-1 in human EpAT.(28) Considering that obesity is frequently associated with insulin re-”
Sinha, S. K., Thakur, R., Jha, M. J., Goel, A., Kumar, V., Kumar, A., Mishra, V., Varma, C. M., Krishna, V., Singh, A. K., et al. (2016) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2468w · Cited by 71
Cited by
The role of adipose tissue in cardiovascular health and disease
Oikonomou, E. K., & Antoniades, C. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0097-6 · Cited by 504
Self-citationEpicardial adipose tissue and cardiovascular diseases
Ansaldo, A. M., Montecucco, F., Sahebkar, A., Dallegri, F., & Carbone, F. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.09.089 · Cited by 247
Czesnikiewicz‐Guzik, M., Nosalski, R., Mikolajczyk, T. P., Vidler, F., Dohnal, T., Dembowska, E., Graham, D., Harrison, D. G., & Guzik, T. J. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14536 · Cited by 61
“, 2014), one should not overlook the possibility that chronic inflammatory processes such as periodontal disease or obese adipose tissue inflammation (Akoumianakis and Antoniades, 2017) can contribute through pre-activating T cells and monocytes and enable their migration to target organs (Barhoumi et al.”
BackgroundJiao, R., Lin, C., Cai, X., Wang, J., Wang, Y., Lv, F., Yang, W., & Ji, L. (2025) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.16012 · Cited by 60
Huang, Y., Liu, Y., Ma, Y., Tu, T., Liu, N., Bai, F., Xiao, Y., Liu, C., Hu, Z., Lin, Q., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.840866 · Cited by 54
Metadata
- Authors
- Akoumianakis, I., & Antoniades, C.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-06-05
- Volume
- 113
- Issue
- 9
- Pages
- 999-1008
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- OpenAlex
- W2624520278
- Cited by
- 148
- References
- 21
- FWCI
- 9.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.